by Lina Olsson | Feb 10, 2022 | News
HiloProbe has CE-marked the ColoNode to satisfy the needs of potential customers who want to start testing the product. – Research Use Only was not enough. Therefore, we have put a lot of focus and resources into completing CE documentation according to IVDD in...
by Lina Olsson | Oct 20, 2021 | News
Den 6 oktober deltog Hiloprobe på Cancerdagen. Här kan du se hela föreläsningen. Det var Marie-Louise Hammarström, professor vid institutionen för klinisk mikrobiologi, Umeå universitet, som på Cancerdagen talade om ett nytt lymfkörteltest för stadieindelning och...
by Lina Olsson | Oct 5, 2021 | News
Hiloprobe deltar på Cancerdagen den 6 oktober för att presentera de nya möjligheter som deras diagnostik-kit Colonode kan ge för behandling av kolorektalcancer. Marie-Louise Hammarström, professor vid institutionen för klinisk mikrobiologi, Umeå universitet, ska tala...
by Lina Olsson | Oct 8, 2020 | News
HiloProbe has been granted SEK 2 million from Swedish Innovation Agency Vinnova to validate a product that detects and helps treat people with colorectal cancer. “This is an important grant for us and means we can validate our product and make it available to the...
by Lina Olsson | Sep 24, 2020 | News
The ColoNode product is now available for research use only! Please, read more about ColoNode at www.colonode.se or click on ColoNode above. Contact us if you are interested to discuss more about ColoNode.
